Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis
(2025)
Journal Article
Jagosh, J., Pearson, M., Greenley, S., Maraveyas, A., Keser, G., Murtagh, F. E. M., Noble, S., Edwards, M., Edwards, A., Højen, A. A., Seddon, K., Klok, F. A., Mooijaart, S. P., Geijteman, E. C. T., & Johnson, M. J. (2025). Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis. PLoS Medicine, 22(8), Article e1004663. https://doi.org/10.1371/journal.pmed.1004663
Introduction
Patients with cancer are at increased risk of thrombotic complications from both the disease and its treatments, with antithrombotic therapy (ATT) usually continued in the last phase of life where the benefit is less clear and there is...
Read More about Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis.